JP2023525359A5 - - Google Patents

Info

Publication number
JP2023525359A5
JP2023525359A5 JP2022569149A JP2022569149A JP2023525359A5 JP 2023525359 A5 JP2023525359 A5 JP 2023525359A5 JP 2022569149 A JP2022569149 A JP 2022569149A JP 2022569149 A JP2022569149 A JP 2022569149A JP 2023525359 A5 JP2023525359 A5 JP 2023525359A5
Authority
JP
Japan
Application number
JP2022569149A
Other languages
Japanese (ja)
Other versions
JP2023525359A (ja
JPWO2021230973A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/022375 external-priority patent/WO2021230973A1/en
Publication of JP2023525359A publication Critical patent/JP2023525359A/ja
Publication of JPWO2021230973A5 publication Critical patent/JPWO2021230973A5/ja
Publication of JP2023525359A5 publication Critical patent/JP2023525359A5/ja
Pending legal-status Critical Current

Links

JP2022569149A 2020-05-15 2021-03-15 Sarsの治療のための化合物 Pending JP2023525359A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063025775P 2020-05-15 2020-05-15
US63/025,775 2020-05-15
US202063120091P 2020-12-01 2020-12-01
US63/120,091 2020-12-01
PCT/US2021/022375 WO2021230973A1 (en) 2020-05-15 2021-03-15 Compounds for the treatment of sars

Publications (3)

Publication Number Publication Date
JP2023525359A JP2023525359A (ja) 2023-06-15
JPWO2021230973A5 JPWO2021230973A5 (https=) 2024-03-27
JP2023525359A5 true JP2023525359A5 (https=) 2024-03-27

Family

ID=78524745

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022569149A Pending JP2023525359A (ja) 2020-05-15 2021-03-15 Sarsの治療のための化合物

Country Status (10)

Country Link
US (1) US20230192671A1 (https=)
EP (1) EP4149535A4 (https=)
JP (1) JP2023525359A (https=)
KR (1) KR20230012528A (https=)
CN (1) CN116209673A (https=)
AU (1) AU2021270608A1 (https=)
BR (1) BR112022023187A2 (https=)
CA (1) CA3178087A1 (https=)
MX (1) MX2022014303A (https=)
WO (1) WO2021230973A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202204338A (zh) * 2020-04-17 2022-02-01 美商帕迪斯生物科學公司 半胱胺酸蛋白酶抑制劑及其使用方法
CN115108970B (zh) * 2021-03-19 2023-08-01 四川大学华西医院 二酰胺类衍生物及其制药用途
CN117777009A (zh) * 2022-12-26 2024-03-29 上海市重大传染病和生物安全研究院 化合物达摩克韦及其应用
KR102760691B1 (ko) 2023-01-31 2025-01-24 두산에너빌리티 주식회사 타이로드 고정 너트 어셈블리 및 이를 포함하는 가스 터빈

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4204002A (en) * 1974-04-09 1980-05-20 Ciba-Geigy Corporation Methods of using N-(substituted)-N-alkoxy carbonyl anilino compounds
US5274167A (en) * 1989-01-26 1993-12-28 Bayer Aktiengesellschaft Polymeriable optically active (meth) acrylic acid derivatives
ES2704862T3 (es) * 2010-07-16 2019-03-20 Agios Pharmaceuticals Inc Composiciones terapéuticamente activas y su método de uso
KR101861869B1 (ko) * 2013-09-10 2018-05-28 경희대학교 산학협력단 신규한 비스-아미드 유도체 및 이의 용도
US10829440B2 (en) * 2015-06-12 2020-11-10 Brown University Antibacterial compounds and methods of making and using same
US9975885B2 (en) * 2016-04-28 2018-05-22 Purdue Research Foundation Broad-spectrum non-covalent coronavirus protease inhibitors
US20200277251A1 (en) * 2017-06-22 2020-09-03 Brown University Novel antibacterial compounds and methods of making and using same

Similar Documents

Publication Publication Date Title
JP2023525359A5 (https=)
CN305632280S (https=)
CN305632644S (https=)
CN305908585S (https=)
CN305907642S (https=)
CN305906862S (https=)
CN305906510S (https=)
CN305904583S (https=)
CN305903951S (https=)
CN305895826S (https=)
CN305884863S (https=)
CN305776263S (https=)
CN305773909S (https=)
CN305770607S (https=)
CN305769368S (https=)
CN305768138S (https=)
CN305535214S (https=)
CN305534725S (https=)
CN305533930S (https=)
CN305533699S (https=)
CN305767631S (https=)
CN305766040S (https=)
CN305917215S (https=)
CN305763178S (https=)
CN305761201S (https=)